DARANIDE

LOE Approaching

dichlorphenamide

NDAORALTABLET
Approved
Jul 1958
Lifecycle
LOE Approaching
Competitive Pressure
30/100

Mechanism of Action

Carbonic Anhydrase Inhibitors

Pharmacologic Class:

Carbonic Anhydrase Inhibitor

Indications (3)

primary hyperkalemic periodic paralysisprimary hypokalemic periodic paralysisrelated variants ( )
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers